Jubilant Pharmova Q1 Results
- BSE: 530019
- NSE: JUBLPHARMA
- ISIN: INE700A01033
- Sector: Biotechnology & Drugs
BSE
952.7
27.95 (3.02%)
27.95 (3.02%)Volume8.88 K
Updated: Tue 14 Jan, 2025 | 15:29:06
NSE
962.337.90 (4.10%)
37.90 (4.10%)Volume2.05 L
Updated: Tue 14 Jan, 2025 | 15:41:24
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Jubilant Pharmova Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,731.70 | 1,758.60 | -1.53% | 1,586.90 | 9.12% |
| Selling/ General/ Admin Expenses Total | 552.90 | 555.00 | -0.38% | 547.70 | 0.95% |
| Depreciation/ Amortization | 90.70 | 101.00 | -10.20% | 89.70 | 1.11% |
| Other Operating Expenses Total | 365.60 | 404.80 | -9.68% | 349.50 | 4.61% |
| Total Operating Expense | 1,175.00 | 1,757.10 | -33.13% | 1,507.00 | -22.03% |
| Operating Income | 556.70 | 1.50 | 37013.33% | 79.90 | 596.75% |
| Net Income Before Taxes | 499.70 | -53.70 | 0.00% | 25.20 | 1882.94% |
| Net Income | 482.10 | -58.60 | 0.00% | 6.40 | 7432.81% |
| Diluted Normalized EPS | 6.34 | 3.25 | 95.25% | 0.40 | 1484.54% |